National Bank of Canada’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
Other funds holding PROF
GS
TIM
RA
GA
LBA
RA
ZCP
MI
AAP
National Bank of Canada's PROF Position: Q1 2026 in Review
National Bank of Canada increased its Profound Medical (PROF) stake by 15% in Q1 2026, buying an estimated $191K and bringing the position to 217,175 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1176.
National Bank of Canada first reported a position in PROF in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.83M in Q4 2022. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.
- National Bank of Canada held 217,175 shares of Profound Medical worth $1.34M as of Q1 2026.
- National Bank of Canada bought 27,665 Profound Medical shares in Q1 2026, an estimated $191K.
- Profound Medical made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1176 holding.
- National Bank of Canada first reported a position in Profound Medical in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's Profound Medical position peaked at $9.83M in Q4 2022.
- 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.